Yazhe Wang
Senior Scientist, Biologics Analytical R&D Merck & Co
Seminars
Wednesday 14th October 2026
Assessing Case Study Characterization & Control of an ADC Variant to Mitigate Analytical Comparability Risk
12:00 pm
- Contextualizing case study of a new ADC impurity identified by reducing CE-SDS in late process development
- Delving into impurity characterization and process control to mitigate risk to ADC quality
- Recapping feedback from Health Authorities to assess if impurity presence was appropriately characterized to mitigate analytical comparability risk
